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INTRODUCTION 
 
Necrotizing fasciitis is a rapidly progressive inflammatory 
infection of the fascia,  with secondary necrosis of the subcutaneous 
tissues. The speed of spread is directly proportional to the thickness of the 
subcutaneous layer. Necrotizing fascitis moves along the fascial plane. 
The patient becomes extremely toxic and later the skin becomes 
painful,  red and necrotic as it is deprived of its blood supply 
 The fascial necrosis is usually wider than the skin involvement 
that is visible clinically.  
Early recognition andsurgical intervention at the earliest is the sole 
factor in preventing the morbidity andmortality in patients with 
necrotising fascitis. 
 The paucity of specific cutaneous signs todistinguish necrotising 
fascitis from other soft tissue infections such as cellulitis makes 
thediagnosis extremely difficult.  
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So a scoring system which is easy to follow and cost effective with 
high positive and negative predictive value is required. 
 One such scoring system is the LRINEC scoring system devised 
by Wong. etal in 2005 which claims to have a positive predictive value of 
92.0% and negative predictive value of 96.0%.  
Hence I would like to modify and validate this scoring system in 
our patients and if found to have similar comparable predictive values,  it 
would prove to be a boon to developing countries like India where the 
mortality of the disease reported ranges from 7 to 76% and also where 
there is also constraint for resources. 
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AIMS AND OBJECTIVES 
 
 
To validate the modified LRINEC scoring system for the diagnosis 
of necrotizing fascitis among patients presenting with soft tissue 
infections to Rajiv Gandhi Govt General Hospitals 
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REVIEW OF LITERATURE 
 
The term necrotizing fascitis (NF) refers to a group of relatively 
uncommon,  and  life-threatening infections of the skin,  soft tissues,  and 
muscles,  which tend to progress rapidly through the fascia planes,  
causing gradual destruction of the fascia at a rate reaching 2–3 cm/h. 
 It usually develops in the lower or upper extremities,  the 
perineum and genital area (Fournier’s gangrene) and in the abdominal 
wall and its swift clinical course is correlated with polymicrobial 
infection and synergy,  which usually co-exists. 
The majority of cases is due to anaerobic bacteria that proliferate in 
a hypoxic environment and produce gas,  which accumulates in the soft 
tissue spaces,  giving the characteristic image of gas gangrene on plain X-
rays and computed tomography (CT) scans. 
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Early diagnosis of NF is crucial. Any delay could prove fatal due to 
increased association with more extensive surgery,  higher rates of 
amputation,  and higher mortality rates.  
 If left untreated,  the infection could lead to systemic 
inflammatory response syndrome (SIRS).  
HISTORY OF NF 
Necrotizing fascitis was first described in 500 BC,  when 
Hippocrates reported a clinical description of a complication of erysipelas 
disease,  resembling the present description of NF 
In France,  Claude Colles,  chief surgeon of the Hotel Dieu in 
Lyon,  described a condition in 1783 that was identical to modern 
descriptions of NF  
The first description of  present day NF was made by Joseph Jones,  
a military surgeon of the army of the Confederate States of America.  
In 1871,  he reported 2, 642 cases of gas gangrene treated in 
hospital during the American Civil War,  with a mortality rate of 
approximately 46%  
In 1952,  Wilson coined the term “necrotizing fascitis”,  and gave a 
more accurate description of this disease. 
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The late 1980s witnessed an increased development in 
understanding this disease. Stevens reported that,  among 20 patients who 
presented with streptococcal shock,  11 were diagnosed as having NF. 
The disease became known to the lay man as “flesh-eating bacteria 
syndrome”. 
SURGICAL ANATOMY OF SKIN AND SUBCUTANEOUS 
TISSUES 
Skin mainly consists of two components – Epidermis and 
Dermis. 
The surface epithelium of skin is the Epidermis and is made of 
keratinized stratified squamous variety. 
Multiple skin appendages are known – sweat gland, sebaceous 
glands, hair and nails – are specialized derivatives of epidermis. 
Epidermis is ectodermal in origin. 
The deeper Dermis is mesodermal in origin and consists mainly 
of collagen fibres together with some elastic tissue, blood vessels, 
lymphatics and nerve fibres. 
The Dermis consists of two layers, the papillary and reticular 
layers. 
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The skin is connected to the underlying bone, muscles or deep 
fascia by a loose areolar connective tissue, this layer is referred to as 
superficial fascia. 
 It is of variable thickness and fat content.  
The neuro vascular structures course in this layer, distributing 
only their terminal branches to the skin. 
The limbs and body are wrapped in a membrane of fibrous tissue 
– the deep fascia. 
The Deep fascia is a dense, organized connective tissue layer, 
devoid of fat, that covers most of the body parallel to the skin and 
subcutaneous tissue (superficial fascia).  
Extensions from its inner surface invest deeper structures, such 
as individual muscles and neuro vascular bundles, as the investing 
fascia. 
In the face and ischioanal fossa distinct layers of deep fascia are 
absent. 
In the limb group of muscles with similar functions sharing the 
same nerve supply are located in compartments, separated by thick 
sheets of deep fascia, called inter muscular septa, that extend 
centrally from surrounding fascial sleeve to attach to the bones. 
19 
 
The deep fascia itself never passes freely over bone, where deep 
fascia contacts bone, it blends firmly with the periosteum. 
Beneath deep fascia are the muscles, the bones, the joints with 
synovial sheaths and the cavities (eg: peritoneal) 
WOUND HEALING 
A clear understanding of healing is vital to a rational approach to  the 
practice of surgery.  
There are three phases of wound healing – 
1 .  Inflammatory phase,   
2. Proliferative phase and 
3. Remodelling phase. 
Inflammatory phase:  
Inflammatory phase begins immediately after wounding and 
lasts 2 to 3 day .Wounding is immediately followed by coagulation, 
altered vascularity, and inflammation, all of which modulate wound 
healing. 
Coagulation is mediated by platelets, and during thrombus formation, 
platelet factors that enhance fibroblast migration and proliferation 
a r e  released. 
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The normal inflammatory response soon follows as small 
blood vessels dilate, capillary permeability increases, and peripheral 
neutrophils and then monocytes migrate into the wound. As 
monocytes ingest material, they are transformed into macrophages 
that phagocytize debris as well as  
enzymatically. destroy bacter ia .  Macrophages  also  play  a  
role  in  the  induction  of  collagen synthesis. 
Prostaglandins also play a significant role in this process. 
Proliferative phase:  (3rd day to 3rd week) 
Proliferative phase lasts from third day to third week 
consisting mainly of fibroblast activity with production of collagen 
and ground substance, growth of new blood vessels as capillary 
loops, and re-epithelisation of wound surface. 
Collagen provides strength and stability for all tissues of the 
body. The strength and integrity of all tissue repairs relies on the 
cross linking and deposition of collagen. 
It is not the collagen synthesis but the collagen cross linking 
that is the bottom line for the surgeon  because  it  is  cross  linking  
that  provides  strength and integrity to any repair. 
21 
 
Collagen degradation,  mediated by enzyme collagenase, is 
equally important as collagen synthesis in wound repair. In normal 
unwounded dermis collagen synthesis and degradation occur in 
equilibrium.  After  wounding, however, the rates of collagen 
synthesis and degradation rise and fall  in  an ordered,  sequential  
fashion,  so  that  enough  collagen  is  synthesized,   
cross linked, deposited, and removed to provide wound 
strength and integrity without excessive  scarring. 
Remodelling phase:  
It is characterized by maturation of collagen (type 1 replacing 
type 3 in the ratio of 4:1). 
There is realignment of collagen fibres along the lines of 
tension, decreased wound vascularity  and wound contraction due to 
fibroblast and myofibroblast  activity. 
The myofibroblasts (a fibroblast-like cell with s moo t h  
musc le  components) are the cells responsible for wound 
contraction. 
It is commonly hypothesized that myofibroblasts are the 
responsible contractile cells and that it is the collagen that holds the  
newly contrac ted  tissues in position. 
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Types of wound healing 
1. Healing by Primary intention  
2. Healing by secondary intention  
3. Delayed primary closure 
Healing by Primary intention 
Healing by primary intention  occurs  when  full  thickness  
wound  edges are approximated shortly after the  primary  wound  has  
been  created. Epithelisation and contraction have little to do with the 
healing by primary closed wounds, even though minimal 
epithelisation occurs within 24 hours and seals the wound from 
bacterial contamination. 
Healing by secondary intention 
This is healing by natural biological processes without 
surgical intervention, which usually occurs in large wounds 
associated with skin and soft tissue loss.  Although  epithelization  
and  collagen  deposition  are  involved, contraction is the most 
important phenomenon in  the  spontaneous  closure  of large open 
wounds. Unless contraction occurs and brings dermal structures 
together, the granulating surface is covered only by a layer of epithelial 
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cells that are useless in providing any coverage with strength and 
integrity. 
Delayed primary closure 
Closure of grossly contaminated incisions/wounds should be 
delayed, allowing time for host inflammatory and immune responses 
to control contamination. Most significant is that delayed primary 
closure does not delay the development of wound strength. 
EPIDEMIOLOGY  
The annual incidence of NF is estimated at 500–1, 000 cases 
annually,  and its prevalence globally has been reported to be 0.40 cases 
Necrotizing fascitis per 100, 000 populations. 
It is seen to have a predilection for men,  with a male-to-female 
ratio of 3:1; this ratio is mainly correlated with the increased incidence of 
Fournier’s gangrene in men. The disease affects all age groups,  although 
middle-aged and elderly patients (over 50 years of age) are more likely to 
be infected.  
The median mortality ratio of NF is a controversial issue. In their 
review of the literature,  Goh et al. concluded that the median mortality 
ratio was 21.5%.  
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However,  its range in the literature is extensive,  varying from 8.7 
to 76%. 
 In regard to NF of the extremities,  the mortality rate is slightly 
lower than that recorded for abdominal and perineal infections. Patients 
with Fournier’s gangrene that has not spread to the abdominal wall tend 
to have a better survival.  
As a general rule,  without treatment,  the mortality rate approaches 
100%. Anaya et al  have demonstrated that infection of the lower 
extremities is the most common site of NF,  followed by the abdomen and 
the perineum. NF of the upper limbs is rare compared to that of the lower 
limbs.  
ETIOLOGY  
Trauma is the most common identifiable etiology.  
The majority of patients have a history of minor or major traumas,  
generally involving external injuries and surgical wounds.  
Appendicitis with perforation,  infection following the repair of an 
incarcerated hernia,  perforated diverticulitis,  necrotic cholecystitis,  
gastroduodenal perforation,  small bowel perforation,  and obstructive 
colon cancer with perforation rank among the most frequent causes of 
complicated intra-abdominal infections that can lead to NF.  
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Notably,  the incidence of NF resulting from a surgical wound in 
the chest wall is greater than that recorded from analogous wounds in the 
lower abdominal wall. Such cases present a high risk of osteomyelitis,  
which substantially increases the mortality of these patients. 
Fournier’s gangrene is often the result of surgical wounds,  skin 
abscess drainage, and pressure sores. 
 It can also present as a complication of colorectal disease due to 
anorectal infection,  ischiorectal abscesses,  and colon perforations. Other 
causes include a possible urethral stricture and a trauma from an 
indwelling Foley catheter. In women,  it has commonly been ascribed to 
Bartholin abscesses or vulval skin infections. In Asia,  consumption of 
raw or undercooked seafood or injury by fish fins can lead to NF (12). In 
this group of infections,  bacteria such as Vibrio spp.,  Aeromonas spp.,  
and Shewanella spp. are commonly involved and are usually known as 
“marine bacteria”. 
CO-MORBIDITIES AND RISK FACTORS  
The most frequent co-morbidity in patients with NF is diabetes 
mellitus. The prevalence of diabetes mellitus in patients with any type of 
NF ranges between 40 and 60%. 
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Other common co-morbidities include liver cirrhosis,  chronic heart 
failure,  obesity,  alcohol abuse,  immunodeficiency,  systemic lupus 
erythematosus,  Addison’s disease,  pre-existing hypertension,  and 
peripheral vascular disease. 
A septic condition and hypotension at the time of admission are 
significant predicting factors for mortality and outcome.  
Chronic renal failure is another indisputable predisposing factor for 
higher mortality in patients with NF. Elevated serum creatinine,  along 
with elevated blood urea,  is also strongly associated with higher 
mortality rates. 
The use of non-steroidal anti-inflammatory drugs (NSAIDs) or 
steroid drugs can suppress fever,  thereby hampering the diagnosis of NF. 
 Furthermore,  Martinschek et al. have demonstrated that an 
increase of serum creatine kinase and lactate parameters,  as well as a 
decrease of serum antithrombin III,  proved by a low INR,  are significant 
parameters for an unfavorable outcome,  particularly in regard to 
Fournier’s gangrene. 
Other risk factors,  such as systemic acidosis,  low hematocrit,  and 
albumin levels,  are also strongly linked with a high mortality,  while 
concomitant conditions increase the mortality rate further. 
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Patients displaying accompanying diseases are usually 
characterized as critically ill and require prolonged intensive care. 
Diabetes,  in particular,  is a disease,  which often combines many of the 
above co-morbidities,  and is hence susceptible to the development of NF. 
However,  the presence of diabetes mellitus has not been proven to 
affect mortality. 
Advanced age constitutes another risk factor for higher incidence 
and mortality,  although somewhat controversial. Large population-based 
studies have shown that advanced age is a strong,  independent predictor 
of mortality. 
A study by Rea and Wyrick reported a mortality rate of 67% in 
patients over 50 years of age and 4% in patients under that age. Other 
studies have concurred that advanced age is a risk factor for higher 
mortality,  but only when accompanied by other risk factors such as renal 
failure,  or delayed surgical debridement. This combination is also 
associated with advanced disease and a more fulminant infection. 
Whether or not patients with NF show a gender predilection with regard 
to mortality is also a topic of debate.  
Fournier’s gangrene shows male predominance with a reported rate 
of 96%. Czymek et al. found that mortality was significantly higher 
among females (50% F vs. 7.7% M). 
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However, studies involving a larger study population have 
concluded that there is no statistical correlation between female gender 
and increased mortality. The extension and variability of infection are 
assumed to increase mortality.  
NF can affect an entire extremity within 24 h,  but it can also show 
slow progression over a period of several weeks. In some patients,  the 
disease remains  
dormant and unexpectedly spreads rapidly without any readily 
apparent reason. 
The factors that lead to the fulminant form of NF,  with a 
potentially lethal outcome within 24 h,  remain unidentified. Some studies 
indicate that the spread of gangrene does not relate to a poorer prognosis. 
Notwithstanding,  the extension of gangrene to the abdominal wall has 
been reported to be directly related to increased mortality.  
PATHOPHYSIOLOGY  
Infection begins in the hypodermis or the superficial fascia,  as the 
more superficial layers (dermis and epidermis) are not affected at the 
beginning.  
The synergistic action of the virulence factors of bacteria and the 
specific factors of the host are implicated in the development of NF.  
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The extension of the infection and necrosis is facilitated by the 
synergy between the different bacteria and toxins and the enzymes they 
produce.  
An anaerobic environment promotes growth of anaerobic bacteria.  
Necrotizing fascitis the hypodermis and superficial fascia is 
directly related to bacterial enzymes that destroy the fascia and fat,  and 
secondarily to vascular origin.  
Invasive bacteria cause thrombosis of the nutrient vessels,  which 
are located in the hypodermis,  leading to tissue ischemia aggravated by 
the presence of edema.  
Tissue ischemia promotes infectious dissemination leading to skin 
necrosis at a later stage. It also explains the intense pain phenomena that 
are usually observed,  especially when the nerve branches are also 
affected. Such cases also display signs of regional hypoesthesia / 
anesthesia.  
The fascial and hypodermic necrotic spread is greater than the 
overlying skin changes. Lymphangitis and lymphadenopathy are rare due 
to thrombosis of the vessels. Gas formed by anaerobic bacteria may lead 
to crepitus.  
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MICROBIOLOGY 
 Recent studies have concluded that NF can be classified into four 
types,  according to microbiological findings 
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TYPE – I: (Poly microbial) 
The most common is type I,  also known as the polymicrobial type. 
Accounting for 70–90% of cases,  it typically affects patients with several 
co-morbidities,  such as diabetes mellitus. Two or more pathogens are 
implicated in this infection (with an average of 4.4 species) and it is 
mostly found in the trunk and perineum.  
TYPE – II (Mono microbial) 
Type II,  otherwise known as monomicrobial,  is defined as 
infection with beta-hemolytic Streptococcus A (Streptococcus pyogenes). 
S. pyogenes is commonly found in young and healthy patients with NF of 
the extremities. Its pathogenesis is explained by the several virulence 
factors produced by this organism. 
 In some cases,  the infection can be associated with 
Staphylococcus aureus. S. aureus secretes toxins,  which cause leukocyte 
destruction and tissue necrosis. Found in the fulminant forms of NF,  S. 
aureus is not easy to manage,  especially when the responsible pathogen 
is the methicillin-resistant S. aureus (MRSA),  which is the case in 10–
30% of all patients.  
Typically,  these infections occur after small incisions,  and appear 
to be highly correlated with the use of NSAIDs. Specifically observed in 
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patients without serious co-morbidities,  the infection is most often found 
in the limbs. The risk of toxic shock syndrome is increased in such cases,  
and the outcome is unfavorable.  
TYPE – III (monomicrobial) 
Type III includes monomicrobial infections involving the 
Clostridium species or Gram-negative bacteria. 
 Clostridium species are anaerobic bacteria that can be produced by 
external injuries (deep wound or crush injury causing local 
devascularization) or surgical wounds (intestinal and obstetric).  
Clostridium infections are currently more frequent among drug 
addicts,  andC. perfringens is the most common bacterium of 
theC.species. Vibrios spp. infections can also lead to type III NF.Vibrio 
vulnificus is a marine bacterium frequently isolated in Asia. Aeromonas 
hydrophila is found in freshwater or low salinity water and in the soil.  
The clinical symptoms of infections by these two bacteria are 
similar; hemorrhagic blisters,  lesions,  and purpuric necrosis are the 
dominant symptoms,  along with the extremely rapid spread of disease.  
TYPE – IV (Fungal) 
Finally,  type IV is the result of fungal infections,  mainly Candida 
spp. and Zygomycetes. This type is found mainly in the 
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immunocompromised host. Infections by these fungi often occur after 
trauma; the clinical image is aggressive and rapidly extensive,  
particularly in immunocompromised patients.  
Microbiological diagnosis is obtained in almost 75% of all cases of 
NF and is based on the good quality of the pre- and intraoperative 
samples and blood cultures.  
Blood cultures are positive in 25% of all cases,  while cultures 
obtained from the site of injury during surgical debridement result as 
positive in 80% of cases.  
Table No:1 Types of Necrotising Fascitis 
TYPE PATHOGENS 
SITE OF 
INFECTION 
CO-
MORBIDITIES 
TYPE - I 
Obligate and facultative 
anaerobes 
Trunk and 
perineum 
Diabetes 
Mellitus 
TYPE - II 
Beta-hemolytic 
streptococcus A 
Limbs  
TYPE - III 
Clostridium species 
 Gram-negative bacteria 
Vibrios spp.  
Aeromonas hydrophila 
Limbs, 
trunk, and 
perineum 
Trauma 
Seafood 
consumption (for 
Aeromonas) 
TYPE - IV 
Candida spp.  
Zygomycetes 
Limbs, 
trunk, 
perineum 
Immuno 
suppression 
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DIAGNOSIS CLINICAL SIGNS AND SYMPTOMS  
Patients with NF usually present with the classic triad of 
symptoms:  
Local pain,   
Swelling,  and  
erythema.  
Tachycardia (>100 beats/min) and fever are the most common vital 
sign abnormalities,  followed by hypotension (SBP < 100 mmHg) and 
tachypnea (>20/min).  
These vital sign abnormalities,  along with the skin erythema,  are 
most useful in securing the diagnosis of NF from other soft tissue 
infections.  
The infected site displays tenderness,  sclerosis,  skin necrosis,  and 
hemorrhagic bullae. Depending on the development of the infection,  the 
clinical image described above may not always be evident. 
 Consequently,  two groups of symptoms are considered,  namely 
early and advanced symptoms.  
The most common early signs are erythema,  local warmth,  skin 
sclerosis,  and edema.  
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However,  in the fulminant form of disease,  the patient is critically 
ill with signs and symptoms of severe septic shock and multiple organ 
dysfunction syndrome,  along with extensive necrosis of soft tissue. In 
this case,  the clinical picture deteriorates rapidly within a few hours; pain 
is severe and usually manifests before the cutaneous signs.  
Remarkably, pain seems to be disproportionate to the clinical 
findings. In contrast,  the subacute form of the disease has a relatively 
slow clinical course,  which may endure for days or weeks.  
The early clinical status of the subacute form is the result of an 
existing Necrotizing fascitis condition leading to infection. The patient 
often presents with a skin infection,  such as folliculitis or abscess,  
gangrene on the extremities,  pressure sore(s),  or a complicated surgical 
wound. Erythema or skin sclerosis is present at the site of infection. 
 The patient usually feels pain at the site of the injury,  and this is a 
very strong diagnostic hint. However,  local nerves can also be infected,  
usually resulting in the partial loss of sensation.  
As the infection develops,  the pain becomes more intense. The 
clinical image is characterized by symptoms of general toxicity including 
fever,  dehydration,  confusion,  dizziness,  diarrhea,  nausea,  vomiting,  
weakness,  and malaise. 
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 If the patient remains undiagnosed or untreated,  the clinical status 
deteriorates rapidly. The cutaneous symptoms may progress to blisters 
and bullae,  ultimately leading to circumscribed necrosis of the skin. 
Initially,  the bullae contain serous fluid,  but,  as the infection progresses,  
they may become hemorrhagic.  
Gas formation can lead to crepitus in the overlying skin,  indicating 
anaerobic infection,  such as C. perfringens.  
This classical skin condition does not normally present until day 
five or later. 
Symptoms of septic shock or MODS frequently appear in the late 
phase of its form.  
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Fig.1 NF – Lower Limb 
Fig.2 NF – Post Debridement 
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Fig.3 – NF – Upper Limb  
 
 Fig 4 – NF – Upper Limb 2 
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As a result,  the patient displays hypotension,  elevated white blood 
cell count,  metabolic acidosis,  coagulopathy,  changes in mental status,  
and weakness. In this late stage of the disease,  the patient looks apathetic 
and indifferent.  
Additional symptoms pertaining to co-morbidities may also 
coexist. The symptoms of disease are not characteristic; hence,  it is often 
misdiagnosed as cellulitis or abscess.  
The most consistent feature of early NF is pain,  which is not in 
proportion to the swelling or erythema. 
42 
 
Moreover,  as a consequence of the enzymatic and toxin action,  
tenderness to palpation extends beyond the area of apparent involvement,  
to spread along fascial plains. In addition,  the margins of involvement 
are usually indistinct,  and lymphangitis is rarely present,  given that the 
infection is in the deep fascia rather than the skin. 
 Cases with upper limb infection do not always present a typical 
picture. In this instance,  patients may appear systemically well. 
Another cause that complicates diagnosis is the absence of fever in 
most cases.  
Several drugs,  such as NSAIDs,  steroids,  and antibiotics can 
lower body temperature and mask fever. 
 For that reason,  the absence of pyrexia does not necessarily 
exclude NF. 
Fournier’s gangrene has a slightly different clinical course. It 
usually begins with pain and itching of the perineum and scrotal skin. 
 In genitourologic types of Fournier’s gangrene,  the pathogens 
pass through the Buck’s fascia of the penis and spread along the Darto’s 
fascia of the scrotum and penis,  Colle’s fascia of the perineum,  and 
Scarpa’s fascia of the lower abdominal wall. 
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Additional necrosis of the superficial fascia and fat produces a thin 
watery malodorous fluid and crepitus. 
 Similarly,  patients may present high fever,  anxiety,  altered 
mental status,  leukocytosis,  shock,  and tachypnea,  when shock is about 
to develop.  
Once clinical signs become obvious,  the appearance resembles the 
late phase of NF,  with visible bruising,  bullae and cutaneous necrosis 
due to the extension of the necrotizing process 
Table No.2 – Stages of NF 
 
Stage 1 (Early) 
Stage 2 
(intermediate) 
Stage 3 (late) 
 
 Tenderness to palpation  
(extending beyond the 
apparent area of skin 
involvement) 
 
 Erythema Swelling 
 Warm to palpation 
Bl 
  Blister or bullae    
formation(serous 
fluid) 
 
  Skin  fluctuance  
 Skin  induration 
 
  Hemorrhagic  bullae  
  Skin  anesthesia  
 Crepitus 
 
 Skin necrosis with 
dusky  discoloration 
progressing to frank 
gangrene 
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BEDSIDE AND LABORATORY TESTS  
Laboratory results in this disease are not usually specific.  
However,  certain laboratory findings can help the clinician to 
differentiate NF from other skin diseases,  such as necrotizing soft tissue 
infection. 
 Specifically,  leukocytosis is a common feature in patients with 
NF (48),  and white blood cell count in excess of 20, 000/L is highly 
suspect.  
Blood urea nitrogen >18 mg/dL and serum creatinine >1.2 mg/dL 
reflect ongoing renal failure,  which is typically present in these patients.  
Serum creatine kinase is also elevated (CK) in patients with severe 
sepsis and MODS. Majeski et al. suggested that C-reactive protein >16 
mg/dL or creatine kinase >600 IU/L generally precludes group A β-
hemolytic streptococcal infection.  
However,  this recommendation is rarely followed by clinicians.  
Several laboratory-based scoring systems have been proposed for 
establishing early diagnosis of NF. 
The Laboratory Risk Indicator for Necrotizing Fascitis (LRINEC) 
proposed by Wong et al. (51–53) is one such example. In addition to 
enabling early recognition of the disease,  this score can also facilitate the 
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classification of patients into risk categories,  and help in the allocation of 
diagnostic resources.  
MODIFIED LRINEC Scoring System 
(Modified Lab Risk Indicators of Necrotising Fascitis 
1. Age 
2. Immunocompromised state 
3. Total white cell count,   
4. hemoglobin,   
5. sodium,   
6. Potassium 
7. glucose,   
8. serum creatinine,  and 
9. C-reactive protein 
 The MODIFIED LRINEC score is a robust score capable of 
detecting even clinically early cases of necrotizing fascitis. The variables 
used are routinely measured to assess severe soft tissue infections. 
Patients with a MODIFIED LRINEC score of >6 should be carefully 
evaluated for the presence of necrotizing fascitis 
46 
 
 The maximum score is 13; 
 a score of >/6 should raise the suspicion of necrotizing fascitis 
and  
 a score of >/8 is strongly predictive of this disease 
 
MODIFIED LRINEC SCORING SYSTEM 
<6 – Implies  Cellulitis stage of STI 
6-7 - Equivocal 
>7 – Implies NF stage of STI 
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Table No.3 – Modified LRINEC Score 
 
S.NO. 
 
VARIABLE 
 
RANGE 
 
SCORE 
1 AGE 
18 - 45 1 
45 - 60 2 
>60 3 
2 
IMMUNO COMPROMISED 
STATE 
ABSENT 0 
PRESENT 2 
3 RANDOM BLOOD SUGAR 
180 OR LESS 0 
>180 1 
4 C- REACTIVE PROTEIN 
NEGATIVE 0 
POSITIVE 2 
5 TOTAL WBC COUNT / mm3 
<15 0 
15 - 25 1 
>25 2 
6 HEMOGLOBIN 
>13.5 0 
11 – 13.5 1 
<11 2 
7 SERUM SODIUM 
135 OR MORE 0 
<135 2 
8 SERUM POTASSIUM 
5 OR LESS 0 
>5 2 
9 SERUM CREATININE 
1.4 OR LESS 0 
>1.4 2 
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Bedside tests,  imaging tests [CT or magnetic resonance imaging 
(MRI)],  or frozen section biopsy can be carried out in patients with 
equivocal clinical findings and a moderate or high risk of NF based on 
the MODIFIED LRINEC score (>6). The finger test and frozen section 
biopsy are used as complementary diagnostic modalities in patients with 
an equivocal diagnosis.  
Surgical exploration is regarded as the mainstay for investigation 
and treatment. The finger test is a bedside procedure performed under 
local anaesthesia by which, a 2-cm incision is made down to the deep 
fascia, at which level gentle probing of the index finger is applied. The 
presence of characteristic “dishwater pus,” along with the lack of 
bleeding and lack of tissue resistance to blunt finger dissection are 
positive findings correlated with NF. Another useful bed side test is an 
incisional biopsy down to the fascial level with an immediate frozen 
section, culture, and Gram stain. The combination of surgical exploration 
and microbiological and histopathological analysis of 1cm3 of soft tissue 
is considered the gold standard for confirming diagnosis, when the latter 
is ambivalent. 
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MANAGEMENT 
Successful management of necrotizing fascitis includes – 
1. Early  diagnosis 
2. Surgical  debridement 
3. Amputation of extremity 
4. Wound care 
5. Antimicrobial  therapy 
6. Intensive supportive care 
7. Hyperbaric  oxygen 
Surgical  debridement 
Adequate surgical  debridement  is essential  to   the  successful 
management of necrotizing fascitis. This will  require radical excision 
of all necrotic tissue, drainage of involved fascial planes, and 
extensive fasciotomy. 
Careful revaluation of the wound and formal re-exploration in 
the operating theatre under general anaesthesia is also  required,  
often  on  two  or three further occasions. 
Surgical debridement is a form of mechanical debridement.  
Mechanical debridement, including sharp debridement,  wet  to  dry  
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dressings  and  high pressure  irrigation  or  pulsed  lavage  are  well  
accepted  therapeutic  measures. 
Thorough sharp debridement of all non viable  soft  tissue  and  
bone  from  the open wound is accomplished mainly with a scalpel, 
tissue nippers, and or curettes. 
Autolytic debridement occurs naturally in a healthy moist 
wound environment with maintained arterial perfusion and venous 
drainage. 
Enzymatic debridement (using topical, proteolytic enzymes such 
as collagenase) however, is  commonly  used as an  adjunctive 
therapy in the management of   wounds. 
Wound  management 
Generally, a moist wound environment bandaged to protect it 
from trauma and  local  contamination  has  been  shown  to  facilitate  
the  healing process. The  type  of dressing depends  upon factors  
such  as   size,  depth, location, and the wound surface 
DRESSINGS: 
The types of dressings can be broadly divided into films,  composites,  
hydrogels, hydrocolloids,  alginates,  foam and  other absorptive 
dressings including NPWT-Negative Pressure Wound Therapy. 
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The choice of one over the other is made by considering the 
wound characteristics and treatment goals. 
TOPICAL  THERAPIES/AGENTS 
Table No. 4 – Types of Topical Therapies 
Saline / amorphous 
hydrogels: skin 
cleansers 
Clean / infected wounds Undefined 
Detergents / antiseptics 
– povidone iodine etc. 
Contaminated or infected 
wounds 
Healthy  granulating 
wounds 
Topical  antibiotics 
silver  sulfadiazine, 
bacitracin,  mupirocin 
etc 
Contaminated or infected 
wounds 
Healthy  granulating 
wounds 
Enzymes  :collagenase, 
papain, urease etc 
Necrotic/escharotic 
wounds 
Healthy or infected 
wounds 
Growth factors – 
becaplermin  gel, 
platelet derived growth 
factors 
Neuropathic diabetic foot 
ulcers 
Infected / necrotic wounds 
Dermal skin substitute- 
Apligraf,  Dennagraft 
Diabetic ulcers,  Venous 
stasis ulcers 
Infected / necrotic wounds 
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NEGATIVE PRESSURE WOUND THERAPY : (NPWT) 
Negative pressure wound therapy  or  vacuum  assisted  wound  
closure consists of the use of a porous sponge within the wound, 
covered by a  
airtight occlusive dressing, to which a vacuum is applied.  
HYPERBARIC  OXYGEN: 
The use of hyerbaric oxygen (HBO) raises  the  dissolved  
oxygen saturation in plasma from 0.3% to nearly 7% . this rise in 
oxygen saturation increases the interstitial diffusion distance of 
oxygen four to fivefold.The broadening use of transcutaneous 
oximetry has permitted evaluation of patients that will likely benefit 
from HBO. 
ANTIBIOTICS: 
Broadspectrum antibiotic coverage is needed especially  in  type  
1  NF, until culture, Gram stain, and sensitivity results are available. 
A number of regimens are employed; a common one is a 
combination of penicillin for gram- positive cocci, an 
aminoglycoside for gram-negative aerobes, a third-generation 
cephalosporin, and clindamycin or metronidazole for anaerobes. 
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Single antibiotic coverage with a broad-spectrum antibiotic 
such as imipenem-cilastatin, which provides coverage against  
anaerobes  and Pseudomonas, can  be  considered.  Clindamycin  also  
suppresses  the  production of both streptococcal toxin and M protein 
and is a preferred choice in the initial antibiotic  therapy. 
Vancomycin is added in case methicillin-resistant S aureus is 
suspected or penicillin allergy is present. In immunocompromised 
patients, adequate coverage of Pseudomonas is important. 
Intravenous immunoglobulin (IV Ig) 
It is postulated to take effect in the treatment of NF by binding 
the streptococcal superantigens and opsonizing bacteria, which 
leads to a decrease in the hyperproliferation of T cells and TNF. 
Sporadic reports  have demonstrated reduced mortality in patients 
receiving IVIg. 
Dermagraft 
This is a wound healing product which consists of neonatal 
dermal fibroblasts cultured in vitro on a bioabsorbable polyglactin 
mesh by tissue engineering technique. This graftskin or dermagraft 
( available as Apligraft ) is  
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an  allogenic  bilayered,  metabolically  active  cultured  skin  
equivalent ,   which has upper epidermal and a lower dermal layer 
and contains human skin cells. 
PLATELET DERIVED GROWTH FACTOR (BECAPLERMIN) 
Becaplerin [recombinant human platelet derived growth factor 
– BB (rh PDGF-BBI)] is quickly emerged as one of the leading 
candidates for clinical trials.It is available in united states as 
Regranex(Becaplermin) gel for treatment of chronic wounds which 
helps in complete  healing. 
GLYCAEMIC  CONTROL 
The control of glucose levels should be as strict as possible, 
and blood glucose levels above 10mmol/L must be avoided, as they 
are associated with impaired function of the leucocytes, both 
polymorphonuclear and mononuclear cells. This degree of glucose 
control should not be achieved by excessive restriction of food 
intake in someone with tissues to heal and an  infection  to combat. 
Insulin will often be required in those not previously receiving it, 
even if only temporary. 
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SMOKING 
The patient should abstain from smoking because of its ill 
effects on the peripheral circulation during wound healing process. 
Patient must be motivated to strictly adhere to the abstinence for better 
response to treatment. 
Skin grafting 
Skin grafts are a standard option for closing defects  that  
cannot  be closed primarily. Skin grafts consist of epidermis and 
some or all of the dermis. 
There are two types of skin grafting - 
1. Split thickness graft (consists of varying amounts of 
dermis) 
2. Full thickness graft (consists of entire dermis) 
All grafts contract immediately after removal from the  donor  
site  and again after re-vascularisation in their final location. 
Primary contraction  is  the  immediate  recoil  of  freshly  
harvested  grafts as a result of elastin in the dermis. More the 
dermis,  more the primary contraction. 
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Secondary contracture, the real nemesis, involves contraction 
of a healed graft  and is probably a result of  myofibroblast activity. 
Granulating wounds left to heal secondarily, without any skin 
grafting, demonstrate the greatest degree of contracture and are most 
prone  to hypertrophic  scarring. 
Common donor sites: 
1. Scalp 
2. Abdominal  wall 
3. Buttocks 
4. Thigh  
Post operation care: 
1. Proper  immobilization 
2. Antibiotics for prevention of infection 
Skin flaps: 
 It has its own blood supply. 
  Required for covering recipient beds that have poor 
vascularity, for covering vital structures, for reconstructing the full 
thickness of eyelids, lips, ears, nose and cheeks and padding bony 
prominences. 
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A skin flap consists of skin and subcutaneous tissue that are 
transferred from one part of the body to another via a vascular pedicle 
or attachment to the body being maintained for nourishment. 
AMPUTATION 
1. Amputation may be necessary  for  acute  or  chronic  
infections  which  is not responding to antibiotics and 
surgical debridement. 
2. Open amputation is indicated in this setting and may be 
performed using one of two methods. 
3. A guillotine amputation may be performed with later 
revision to a more proximal level after the infection is 
under control. 
4. Alternatively an open amputation may be performed  at  the  
definitive level by initially inverting the flaps and packing the 
wound open with secondary closure 10 to 14 days later. 
 In the acute  setting,  the  most  worrisome  infections  are  those  
produced by gas forming organisms. 
Three distinct gas forming infections must be differentiated: 
1. Anaerobic  cellulitis/NF 
2. Clostridial  myoneorosis 
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3. Streptococcal  myoneorosis 
The systematic effects of a refractory infection may justify 
amputation. 
Open amputations : 
An open amputation is one in which the skin is not closed 
over the end of the stamp.The operation is first of at least two 
operations required to construct a satisfactory stump. 
It must always be followed  by  secondary  closure,  
reamputation, revision or plastic repair. 
The purpose of this type of amputation is to prevent or 
eliminate infection so that final closure of the stump may be done 
without breakdown of the wound. 
It is indicated in infections and in severe traumatic wounds. 
A wound vaccum assisted closure is applied to the open  stump 
immediately  after  initial  debridement.  Subsequent  debridements  
are  scheduled at 48 hr intervals. Reapplied after each debridement 
until wound is ready  for closure. 
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Complications of amputation: 
1. Hematoma 
2. Infection 
3. Wound  necrosis 
4. Contractures 
5. Pain 
Amputations of lower extremity: 
1. Transtibial  amputations: 
The importance of preserving the patients own  knee  joint  in  
the successful rehabilitation of a patient with a lower extremity 
amputation cannot be over emphasized. 
Transibial amputations can be divided into 3  levels.  The  
appropriate level must be determined for each individual patient. 
In adults, ideal bone length for a below knee amputation stump is 
12.5 to 17.5 cms, depending on body height.(rule of thumbs 2.5 for 
each 30 cm height)55 
Ideal/most satisfactory level is  about  15cms  distal  to  medial  
tibial articular surface.A stump less than 12.5 cm is less sufficient. 
2. Disarticulation of knee: 
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3. It results in an excellent end bearing stump. 
4. Its use in elderly is limited. 
3.Transfemoral  amputations: 
Above knee amputations are classified as short transfemoral, 
medial transfemoral, log transfemoral and supracondylar. 
Amputation through thigh is second in frequency to only to 
transtibial amputation. 
Here patients knee joint is lost. So it is  extremely  important  
for  the stump to be as long as possible to provide a strong lever 
arm for control of the prosthesis. 
4.Disarticulation of the hip: 
Hip disarticulation occasionally is indicated after massive 
trauma, for arterial insufficiency, for infection like necrotizing 
fascitis or for  certain congenital limb deficiencies. 
5.Hemipelvectomy: 
Most often performed far tumors that cannot  be adequately 
resected by limb sparing techniques or hip disarticulation. Other 
indications are  life threatening  infection/arterial  insufficiency. 
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MATERIALS AND METHODS 
 
The data for the study was obtained from patients 
hospitalized with a provisional diagnosis of necrotizing fascitis on  
clinical evaluation and who are admitted at Rajiv Gandhi Govt. 
General Hospital. Patients presenting with signs and symptoms of 
Necrotizing Fascitis admitted during January 2017 to September 
2017 at Rajiv Gandhi Govt. General Hospital, were counseled for 
investigation and treatment of Necrotizing Fascitis and its 
complication. 50 patients were treated in the above hospital. 
 
Exclusion criteria: 
 Patients below 15 yrs or above 75 yrs of age 
 Patients who have received antibiotic treatment in the last 48 
hrs or have received a minimum of three doses of antibiotics 
prior to presentation. 
 Patients who have undergone surgical debridement for present 
episode of STIs. 
 Patients with burns or furuncles with no evidence of cellulitis. 
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Assessment of parameters: 
 All consenting patients with necrotizing fascitis would be clinically 
examined after history taking and then subjected to blood investigations 
as follows : 
 C-reactive protein 
 Total white cell count 
 Hemoglobin 
 Sodium 
 Potassium 
 Creatinine 
 Glucose 
Name, age,  occupation,  socioeconomic  status,  residence  
were  recorded.   The  presenting  complaints  and  details  were 
recorded in chronological order. 
Detailed physical  examination  including  nutritional  status,  
built,  status of vascular system and neurological system were 
recorded. Detailed local examination of involved part done . 
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On admission,  general  and medical treatment of necrotizing 
fascitis was done and followed by wound debridement as the 
definitive procedure . The patients were later  managed  by regular 
wound dressings,  antibiotics,  and supportive therapy for 
maintenance of blood pressure and renal status and in few cases 
vacuum assisted dressings were tried for faster healing . Once the 
wound was healthy split skin grafting and secondary suturing was 
done in most cases . Some cases healed by secondary intention . 
Some cases had to undergo major amputations for control of 
infection and its spread . 
Diabetic patients were managed by diabetic treatment like 
diabetic diet, sugar restriction and anti diabetic treatment was given 
with oral hypoglycaemic drugs and insulin. 
Patients who developed renal complications were managed by 
salt restrictions,  dialysis and supportive renal treatment. 
Supportive treatment was given for patients who had bed sores 
as a complication of NF  by regular dressings and water beds . 
Patients who went into septicaemia were managed in 
intensive care units on ventilators under guidance of anaesthetists 
and physicians. 
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Post discharge patients were followed up to one month 
regularly on out patient basis for dressings,  further  management  of  
diabetes  and  hypertension and also to review liver and renal 
parameters. 
Major amputation patients were advised rehabilitation and 
prosthesis were recommended 4 weeks after surgery. 
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RESULTS – TABLES AND BAR/PIE CHARTS 
SEX 
 
 
 
 
 
Sex Frequency Percent 
Female 22 44.0 
Male 28 56.0 
Total 50 100.0 
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AGE 
AGE Frequency Percent 
35-40 3 6.0 
40-50 19 38.0 
>50 28 56.0 
Total 50 100.0 
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Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
35 1 2.0 2.0 2.0 
39 1 2.0 2.0 4.0 
40 1 2.0 2.0 6.0 
42 5 10.0 10.0 16.0 
43 1 2.0 2.0 18.0 
46 4 8.0 8.0 26.0 
48 6 12.0 12.0 38.0 
49 2 4.0 4.0 42.0 
50 1 2.0 2.0 44.0 
51 5 10.0 10.0 54.0 
52 1 2.0 2.0 56.0 
53 3 6.0 6.0 62.0 
54 4 8.0 8.0 70.0 
56 2 4.0 4.0 74.0 
57 2 4.0 4.0 78.0 
58 4 8.0 8.0 86.0 
59 3 6.0 6.0 92.0 
60 1 2.0 2.0 94.0 
61 2 4.0 4.0 98.0 
62 1 2.0 2.0 100.0 
Total 50 100.0 100.0 
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TOTAL COUNT PER CUBIC MM 
 
TC Frequency Percent 
<15 / cu.mm 20 40.0 
15-25/ cu.mm 21 42.0 
>25/ cu.mm 9 18.0 
Total 50 100.0 
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HEMOGLOBIN IN GRAM PER DECILITRE 
 
 
 
 
Hemoglobin Frequency Percent 
13.5gm/dl 10 20.0 
11-13.5gm/dl 15 30.0 
<11gm/dl 25 50.0 
Total 50 100.0 
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SERUM SODIUM IN mEq/dL 
Na Frequency Percent 
<135 mEq/dL 36 72.0 
≥135 mEq/dL 14 28.0 
Total 50 100.0 
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SERUM CREATININE mg/dL 
 
 
 
 
 
Creatinine Levels Frequency Percent 
<=1.4 mg/dL 15 30.0 
>1.4 mg/dL 35 70.0 
Total 50 100.0 
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RANDOM BLOOD SUGAR LEVELS IN mgs/dL 
 
 
 
 
 
 
 
  
 
 
 
 
RBS Level Frequency Percent 
<180 mgs/dL 16 32.0 
>180 mgs/dL 34 68.0 
Total 50 100.0 
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SERUM POTASSIUM IN mEq/dL 
K Frequency Percent 
>/5.1 mEq/dL 9 18.0 
3.5 to 5 mEq/dL 30 60.0 
<3.5 mEq/dL 11 22.0 
Total 50 100.0 
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SERUM CRP  
 
CRP Frequency Percent 
+ 19 38.0 
- 31 62.0 
Total 50 100.0 
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IMMUNOCOMPROMISED STATE  
 
IM state Frequency Percent 
NO IC 25 50.0 
IC 25 50.0 
Total 50 100.0 
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CO – MORBIDITIES 
Co Morb Frequency Percent 
DM 19 38.0 
PVD 15 30.0 
HTN 9 18.0 
CKD 2 4.0 
MAL 5 10.0 
Total 50 100.0 
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MODIFIED LRINEC SCORE 
 
 
 
      
 
M-LRINEC SCORE Frequency Percent 
<6 15 30.0 
6 to 7 8 16.0 
>8 27 54.0 
Total 50 100.0 
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NUMBER OF DEBRIDEMENTS 
 
No of Deb Frequency Percent 
<3 38 76.0 
>/3 12 24.0 
Total 50 100.0 
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AMPUTATIONS 
 
AMPUTATIONS Frequency Percent 
+ 28 56.0 
- 22 44.0 
Total 50 100.0 
 
 
56%
44%
Amputations
Amputations+ Amputations-
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OUTCOME 
outcome Frequency Percent 
discharged 45 90.0 
death 5 10.0 
Total 50 100.0 
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HOSPITAL STAY 
 
Stay Frequency Percent 
<10 DAYS 37 74.0 
>/=10 DAYS 13 26.0 
Total 50 100.0 
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DISCUSSION  
  
Necrotizing fascitis was first described as a rapidly spreading 
gangrene of the subcutaneous tissue caused by beta hemolytic 
streptococci group A. This disease was later considered as a clinical 
entity rather than a specific bacterial infection . Many virulent organisms 
can cause necrotizing fascitis. 
Necrotizing fascitis is a surgical emergency . Early recognition and 
prompt aggressive surgical debridement of all necrotic tissue is critical 
for survival.  
Early diagnosis of the presence of a necrotizing soft tissue 
infection is critical if optimal outcomes are to be achieved. Distinguishing 
a NSTI that necessitates surgical debridement from a non necrotizing 
cellulitis that responds solely to antibiotic therapy however can be 
difficult. Unfortunately,  any delay in diagnosis is potentially 
catastrophic,  because the concomitant delay in appropriate surgical 
therapy has been shown to increase mortality 
We have diagnosed necrotizing fascitis whenever there is a 
necrosis of subcutaneous tissues extending through the fascial planes . 
Paucity of cutaneous findings early in the course of disease makes it 
difficult to diagnose the condition early . often the disease is masqueraded 
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as cellulitis or abscesses . In these patients diagnosis has been made when 
the infection progressed despite treatment with broad spectrum 
intravenous antibiotics. 
It has been shown by numerous studies in the past that early 
recognition and surgical intervention at the earliest is the sole factor in 
preventing the morbidity and mortality in patients with necrotising 
fascitis. 
The paucity of specific cutaneous signs to distinguish necrotising 
fascitis from other soft tissue infections such as cellulitis makes the 
diagnosis extremely difficult. So a scoring system which is easy to follow 
and cost effective with high positive and negative predictive value is 
required. 
One such scoring system is the LRINEC scoring system devised by 
Wong. etal in 2005 which claims to have a positive predictive value of 
92.0% and negative predictive value of 96.0%. Hence we would like to 
modify and validate this scoring system in our patients and if found to 
have similar comparable predictive values,  it would prove to be a boon to 
developing countries like India where the mortality of the disease 
reported ranges from 7 to 76% and also where there is also constraint for 
resources 
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CROSS TABULATION RESULTS 
 
CROSS TAB – M-LRINEC SCORE VS NO. OF DEBRIDEMENTS 
 
 
No of Debridements Total 
M-LRINEC 
SCORE 
<3 >3 
 
<6 8 1 9 
6 to 7 7 3 10 
>/8 23 8 31 
 
38 12 50 
 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 1.073a 2 .585 
Likelihood Ratio 1.208 2 .547 
Linear-by-Linear 
Association 
.524 1 .469 
N of Valid Cases 50 
  
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 2.16.  
 
About 16% of patients with Modified LRINEC score 0f >8 had 
repeated Debridements with P-value of test 0.585 
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CROSS TAB – M-LRINEC VS SERUM CRP 
 
 
SERUM CRP 
 
Total 
M-LRINEC SCORE + - 
 
<6 5 4 9 
6-7 4 6 10 
>8 10 21 31 
 
19 31 50 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 1.628a 2 .443 
Likelihood Ratio 1.595 2 .450 
Linear-by-Linear 
Association 
1.549 1 .213 
N of Valid Cases 50 
  
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 3.42.  
 
 About 42% of patients with Modified LRINEC Score of >8 had + 
Serum CRP values with P-value 0.443 
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CROSS TAB – M-LRINEC VS TOTAL COUNT 
 
TC Total 
M-LRINEC 
SCORE 
<15 15-25 >25 
 
<6 4 3 2 9 
6-7 6 2 2 10 
>8 10 16 5 31 
 
20 21 9 50 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig.                    
(2-sided) 
Pearson Chi-Square 3.676a 4 .452 
Likelihood Ratio 3.814 4 .432 
Linear-by-Linear 
Association 
.206 1 .650 
N of Valid Cases 50 
  
a. 6 cells (66.7%) have expected count less than 5. The 
minimum expected count is 1.62.  
 
About 10% of patients with Modified LRINEC Score of >8 had 
Total counts >25/mm3 and 32% of patients had Total Counts between 15-
25/mm3 with P-value of 0.452 
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CROSS TAB – M-LRINEC SCORE VS HEMOGLOBIN 
 
Hb IN g/dL Total 
M-LRINEC 
SCORE 
>13.5 11-13, 5 <11 
 
1 4 2 3 9 
2 1 6 3 10 
3 5 7 19 31 
 
10 15 25 50 
 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 9.262a 4 .055 
Likelihood Ratio 8.230 4 .084 
Linear-by-Linear 
Association 
3.739 1 .053 
N of Valid Cases 50 
  
a. 5 cells (55.6%) have expected count less than 5. The 
minimum expected count is 1.80.  
 
About 42% of patients with Modified LRINEC Score of >8 had 
Hemoglobin <11 g/dL with P-value 0.55 
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CROSS TAB – M-LRINEC VS SERUM SODIUM 
 
Na Total 
M-LRINEC SCORE >135 mEq/dL <135mEq/dL 
 
1 8 1 9 
2 9 1 10 
3 19 12 31 
 
36 14 50 
 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 4.644a 2 .098 
Likelihood Ratio 5.134 2 .077 
Linear-by-Linear 
Association 
3.756 1 .053 
N of Valid Cases 50 
  
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 2.52.  
 
About 24% of patients with Modified LRINEC Score of >8 had 
Increased Serum Sodium levels with P-value 0.098 
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CROSS TAB – M-LRINEC VS SERUM CREATININE 
 
SERUM CREATININE IN 
mgs/dL 
Total 
M-LRINEC SCORE <1.4 >1.4 
 
<6 3 6 9 
6-7 4 6 10 
<8 8 23 31 
 
15 35 50 
 
Chi-Square Tests       
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square .783a 2 .676 
Likelihood Ratio .766 2 .682 
Linear-by-Linear 
Association 
.394 1 .530 
N of Valid Cases 50     
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 2.70. 
  
 
About 46% of patients with Modified LRINEC Score of >8 had 
Serum Creatinine levels >1.4 mgs/dL with P-value 0.676 
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CROSS TAB – M-LRINEC VS RANDOM BLOOD SUGAR 
 
RBS levels in g/dL Total 
M-LRINEC 
SCORE 
<180 >180 
 
<6 3 6 9 
6-7 3 7 10 
>7 10 21 31 
 
16 34 50 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square .027a 2 .987 
Likelihood Ratio .027 2 .987 
Linear-by-Linear 
Association 
.000 1 .988 
N of Valid Cases 50 
  
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 2.88.  
 
About 42% of patients with Modified LRINEC Score of >8 had 
RBS values >180 mgs/dL with P-value 0.987 
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CROSS TAB – M-LRINEC VS SERUM POTASSIUM 
 
 
SERUM POTASSIUM IN mEq/dL 
 
Total 
M-LRINEC 
SCORE 
<3.5 3.5-5 >5.1 
 
<6 0 4 5 9 
6-7 2 5 3 10 
>8 7 21 3 31 
 
9 30 11 50 
 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig.                 
(2-sided) 
Pearson Chi-Square 9.880a 4 .043 
Likelihood Ratio 10.666 4 .031 
Linear-by-Linear 
Association 
7.919 1 .005 
N of Valid Cases 50 
  
a. 4 cells (44.4%) have expected count less than 5. The 
minimum expected count is 1.62.  
 
About 14% of patients with Modified LRINEC Score of >8 had 
Serum Potassium >5.1 mEq/dL and 6% of patients with Modified 
LRINEC Score >8  had Serum Potassium <3.5 mEq/dL with P-value 
0.043 
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CROSS TAB M-LRINEC VS CO – MORBIDITIES 
 
 
CO - MORBIDITIES 
 
Total 
M-LRINEC 
SCORE 
DM PVD SHT CKD MAL 
 
<6 5 1 3 0 0 9 
6-7 2 3 3 0 2 10 
>8 12 11 3 2 3 31 
 
19 15 9 2 5 50 
 
 
About 24% of patients with Modified LRINEC Score of >8 had 
DIABETES MELLITUS with P-value 0.320 
Chi-Square Tests 
   
 
Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-
Square 
9.265a 8 .320 
Likelihood Ratio 10.908 8 .207 
Linear-by-Linear 
Association 
.085 1 .771 
N of Valid Cases 50 
  
a. 12 cells (80.0%) have expected count less than 5. The 
minimum expected count is .36.  
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CROSS TAB M-LRINEC VS HOSPITAL STAY 
 
HOSPITAL STAY Total 
M-LRINEC SCORE <10 DAYS >10 DAYS 
 
<6 9 0 9 
6-7 8 2 10 
>8 20 11 31 
 
37 13 50 
 
Chi-Square Tests       
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 4.798a 2 .091 
Likelihood Ratio 6.973 2 .031 
Linear-by-Linear 
Association 
4.683 1 .030 
N of Valid Cases 50     
a. 2 cells (33.3%) have expected count less than 5. The 
minimum expected count is 2.34. 
  
 
About 22% of patients with Modified LRINEC Score of >8 had 
Hospital stay >10 days with P-value 0.091 
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CROSS TAB – M-LRINEC VS AMPUTATIONS 
 
 
Amputation 
Total 
M-LRINEC SCORE + - 
 
<6 7 2 9 
6-7 6 4 10 
>8 15 16 31 
 
28 22 50 
 
Chi-Square Tests       
 Value df 
Asymp. Sig.                   
(2-sided) 
Pearson Chi-
Square 
2.526a 2 .283 
Likelihood Ratio 2.655 2 .265 
Linear-by-Linear 
Association 
2.448 1 .118 
N of Valid Cases 50     
a. 2 cells (33.3%) have expected count less than 
5. The minimum expected count is 3.96. 
  
 
About 32% of patients with Modified LRINEC Score of >8 
underwent Amputations with P-value 0.283 
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SUMMARY 
1. Necrotising Fascitis is a surgical emergency. Early diagnosis of this 
life threatening infection is crucial prognostic factor for patient 
survival and relies on proper interpretation of physical findings.  
2. This study was conducted of 50 consecutive selected patients. 
3. Youngest in this series was 19 years and oldest in this series was 83 
years with commonest age group being 50-60. 
4. Mean Age of Incidence was 50.96 with SD 6.5681 – 10% 
5. Mean Hospital Stay was 8.32 days with SD 6.1856 
6. Mean number of debridements was 1.93 with SD 1.0382 
7. Male:Female sex ratio was found to be 5.6:4.4 with Male 
predominance. 
8. 62% of our patients had Positive CRP in Necrotising Fascitis 
9. About 42% of patients with NF had Total Counts between 15-25/ 
cubic mm. 
10. About 50% of patients with NF had Hemoglobin of <11g/dL 
11. Most of the patients with NF of about 72% who are in 
Hypernatremia. 
12. Most of the patients with NF of about 70% had elevated Serum 
Creatinine. 
13. About 68% of patients had Increased RBS 
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14. About 18% of patients with NF presented with Hyperkalemia and 
about 22% with Hypokalemia. 
15. Most of the patients were found to be associated with 
Immunocompromised state about 50%. 
16. Most common co-morbid illness associated with NF found in our 
study was Diabetes Mellitus about 38%. 
17. About 24% of patients in NF were undergone repeated 
debridements more than 3 times. 
18. About 56% of patients in our study had undergone amputations of 
limb at different levels as Life saving procedure. Most of them had 
Peripheral Vascular Disease as Co-morbid condition,  
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CONCLUSION 
 
This study shows that: 
1. There exists a statistically significant correlation between  
MODIFIED LRINEC scoring system and prognosis of 
Necrotizing fascitis 
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ANNEXURE 
PATIENT PROFORMA 
Name:      
Age:    
Sex: 
IP No. : 
DOA:         
DOD: 
Diagnosis: 
Presenting complaints: 
Co-morbid illness: 
Past surgical /Medical history: 
On examination:  
General condition: 
VITALS: 
PR:                             BP:                           RR:                        
CVS: 
RS: 
P/A: 
L/E: 
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MODIFIED LRINEC SCORE 
 
S.NO. VARIABLE RANGE 
SCORE 
CRITERIA 
SCORE OBTAINED 
1 AGE 
18 - 45 1 
 45 - 60 2 
>60 3 
2 
IMMUNO 
COMPROMISED 
STATE 
ABSENT 0 
 
PRESENT 2 
3 
RANDOM BLOOD 
SUGAR 
180 OR LESS 0 
 
>180 1 
4 
C- REACTIVE 
PROTEIN 
NEGATIVE 0 
 
POSITIVE 2 
5 
TOTAL WBC 
COUNT / mm3 
<15 0 
 15 - 25 1 
>25 2 
6 HEMOGLOBIN 
>13.5 0 
 11 – 13.5 1 
<11 2 
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7 SERUM SODIUM 
135 OR MORE 0 
 
<135 2 
8 
SERUM 
POTASSIUM 
5 OR LESS 0 
 
>5 2 
9 
SERUM 
CREATININE 
1.4 OR LESS 0 
 
>1.4 2 
 
 
TOTAL SCORE: 
 
Outcome: 
No. of Debridements : 
Length of hospital stay: 
Amputation: 
  Mortality: 
Condition on discharge 
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